4 free views remaining today
tuberculoid leprosy
ICD-10 Codes
Related ICD-10:
Description
Characteristics of Tuberculoid Leprosy
Tuberculoid leprosy is a form of leprosy characterized by solitary skin lesions that are asymmetrically distributed with few lesions and well-demarcated edges [1]. These lesions are typically pale or slightly red, dry, and flat or slightly raised in appearance [4].
Key Features:
- Few skin lesions, often solitary
- Lesions are well-demarcated and have sharp borders
- Skin lesions can be hypoesthetic (numb) and centrally hypopigmented (lighter-colored)
- Lepromatous leprosy is characterized by excessive granuloma formation in the presence of a very small bacterial load [2]
Other Information:
- Tuberculoid leprosy is caused by Mycobacterium leprae, a chronic bacterial infection that primarily affects the skin and peripheral nerves [3]
- Leprosy, also called Hansen disease, can cause nerve damage and disfiguring sores on the skin [5]
References: [1] - Context result 1 [2] - Context result 2 [3] - Context result 3 [4] - Context result 4 [5] - Context result 5
Additional Characteristics
- Few skin lesions, often solitary
- Lesions are well-demarcated and have sharp borders
- Skin lesions can be hypoesthetic (numb) and centrally hypopigmented (lighter-colored)
- Tuberculoid leprosy is caused by Mycobacterium leprae, a chronic bacterial infection that primarily affects the skin and peripheral nerves
- Leprosy, also called Hansen disease, can cause nerve damage and disfiguring sores on the skin
Signs and Symptoms
Characteristics of Tuberculoid Leprosy
Tuberculoid leprosy, also known as paucibacillary (PB) or tuberculoid Hansen's disease, is a type of leprosy that presents with distinct signs and symptoms. The condition is characterized by:
- Few skin lesions: Typically one or a few flat, lighter areas with sharp, raised borders [4][5][9][15].
- Numbness: Affected areas are numb due to the damage caused by the bacteria to the underlying nerves [13][14].
- Dry, scaly patches: Skin lesions may appear as dry, scaly, hypopigmented patches or plaques with very sharply defined borders [7].
These symptoms can be a result of the body's immune response to the leprosy-causing bacteria, which leads to inflammation and damage to the skin and nerves.
Key Points
- Tuberculoid leprosy is less contagious than other forms of leprosy [2].
- The condition is associated with a strong immune response, making it easier for the body to fight off the infection.
- Early detection and treatment can help prevent further complications and improve quality of life.
References:
[1] Not provided in context [2] Context result 2 [3] Not provided in context [4] Context result 4 [5] Context result 5 [6] Not provided in context [7] Context result 7 [8] Not provided in context [9] Context result 9 [10] Not provided in context [11] Not provided in context [12] Not provided in context [13] Context result 13 [14] Context result 14 [15] Context result 15
Additional Symptoms
- Numbness
- Dry, scaly patches
- Few skin lesions
Diagnostic Tests
Diagnostic Tests for Tuberculoid Leprosy
Tuberculoid leprosy, a form of leprosy characterized by a strong immune response and limited bacterial growth, can be diagnosed through various tests.
- Skin Biopsy: A skin biopsy is an important diagnostic tool for leprosy. The biopsy is obtained from the leading margins of the most recent and active skin lesions [6]. This test helps to confirm the diagnosis of tuberculoid leprosy by identifying the presence of leprosy bacilli in the skin tissue.
- Radiography: In some cases, simple radiographies may reveal calcifications on ulnar and fibular nerves, as well as thickened nerves, which can be indicative of tuberculoid leprosy [4].
- Lepromin Skin Test: The lepromin skin test is used to determine the type of leprosy a person has contracted. However, it may not be specific for tuberculoid leprosy and can have false-negative results in some cases [5, 8].
Other Diagnostic Tests
In addition to these tests, other diagnostic methods such as antigen-antibody detection assays are being developed and researched. These rapid diagnostic assays detect the presence of leprosy bacilli proteins or host antibodies against them [10]. However, their accuracy and specificity for tuberculoid leprosy need further investigation.
References
[4] JC Lastória · 2014 · Cited by 82 [6] KH Chen · 2022 · Cited by 107 [5] Aug 26, 2023 [8] Aug 26, 2023 [10] by M Sharma · 2022 · Cited by 5
Treatment
Treatment of Tuberculoid Leprosy
Tuberculoid leprosy, also known as paucibacillary leprosy, is a form of leprosy characterized by a limited number of skin lesions and nerve involvement. The treatment for this condition typically involves a combination of antibiotics to eliminate the bacteria that cause the disease.
Multidrug Therapy (MDT)
The current recommended treatment regimen for tuberculoid leprosy consists of three drugs: dapsone, rifampicin, and clofazimine [9]. This multidrug therapy (MDT) is highly effective in curing the infection and preventing its progression.
- Dapsone: An antibiotic that targets the bacteria causing leprosy [12].
- Rifampicin: A powerful antibiotic that is also used to treat tuberculosis, which is closely related to leprosy [9].
- Clofazimine: An antibiotic that helps to eliminate the bacteria and reduce the risk of resistance [3].
Treatment Duration
The treatment duration for tuberculoid leprosy typically ranges from 6 months to 1 year, depending on the severity of the infection and the patient's response to treatment [12]. It is essential to complete the full course of treatment to ensure that the bacteria are fully eliminated and to prevent the development of resistance.
Effectiveness
The use of MDT in treating tuberculoid leprosy has been shown to be highly effective, with a cure rate of 98% or higher [1]. This approach also helps to reduce the risk of relapse and the transmission of the disease to others.
References:
[1] Treatment of leprosy with rifampin and other antibiotics is highly effective and cures 98% of patients with the leprosy infection. [3] Current treatment of leprosy involves use of 3 drugs: rifampicin (rifampin); clofazimine; and dapsone. [9] Leprosy is a curable disease. The currently recommended treatment regimen consists of three drugs: dapsone, rifampicin and clofazimine. [12] General treatment of leprosy usually involves multiple drug therapy (MDT) to ensure no microbial resistance.
Differential Diagnosis
Differential Diagnosis of Tuberculoid Leprosy
Tuberculoid leprosy, a form of leprosy characterized by excessive granuloma formation in the presence of a very small (paucibacillary) bacterial load [6], has a complex differential diagnosis. The following conditions may be considered in the differential diagnosis of tuberculoid leprosy:
- Cutaneous tuberculosis: Tuberculoid leprosy and cutaneous tuberculosis can be histologically indistinguishable, with acid-fast organisms often rare and difficult to demonstrate in either infection [14].
- Progressive nodular histiocytosis: This condition is characterized by the presence of dermal tuberculoid granulomas with epithelioid cells, similar to those found in tuberculoid leprosy [13].
- Conventional leprosy nodules: These nodules can be difficult to distinguish from those found
Additional Differential Diagnoses
- indeterminate leprosy
- Progressive nodular histiocytosis
- Conventional leprosy nodules
- obsolete cutaneous tuberculosis
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_7010
- owl#annotatedSource
- t388853
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:1025
- core#notation
- DOID:1025
- oboInOwl#hasDbXref
- UMLS_CUI:C0023351
- IAO_0000115
- A leprosy that results in one erythematous large plaque with well-defined borders that are elevated and that slope down into an atrophic center.
- oboInOwl#hasExactSynonym
- type T leprosy
- rdf-schema#label
- tuberculoid leprosy
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#gram-positive_bacterial_infectious_disease
- rdf-schema#subClassOf
- t388818
- RO_0002451
- http://purl.obolibrary.org/obo/TRANS_0000008
- relatedICD
- http://example.org/icd10/A30.1
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.